JUNS Projected Dividend Yield
Jupiter Neurosciences Inc ( NASDAQ : JUNS )Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. Co. has developed a resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL™, has various potential indications of use for diseases, which of Co. is primarily targeting Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes syndrome and with Amyotrophic Lateral Sclerosis in an early development stage. In the larger disease areas, Co. is primarily targeting Mild Cognitive Impairment/early Alzheimer's disease with Traumatic Brain Injury /concussions and Covid-19 in early development stages. 21 YEAR PERFORMANCE RESULTS |
JUNS Dividend History Detail JUNS Dividend News JUNS Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |